Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes

[1]  Dmitri Nesteruk,et al.  The Functional Perspective , 2020, Design Patterns in .NET Core 3.

[2]  Lin Lu,et al.  Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders , 2019, Neuroscience Bulletin.

[3]  K. Domschke,et al.  Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders , 2018, Genes, brain, and behavior.

[4]  A. Hamm,et al.  Cue and context conditioning to respiratory threat: Effects of suffocation fear and implications for the etiology of panic disorder. , 2018, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[5]  Orexin modulates behavioral fear expression through the locus coeruleus , 2017, Nature Communications.

[6]  R. Valentino,et al.  Orexins Mediate Sex Differences in the Stress Response and in Cognitive Flexibility , 2017, Biological Psychiatry.

[7]  S. Cichon,et al.  GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder , 2017, Molecular Psychiatry.

[8]  Guohua Li,et al.  Increased plasma orexin-A levels in patients with insomnia disorder are not associated with prepro-orexin or orexin receptor gene polymorphisms , 2017, Peptides.

[9]  A. Gloster,et al.  Panic disorder with agoraphobia from a behavioral neuroscience perspective: Applying the research principles formulated by the Research Domain Criteria (RDoC) initiative. , 2016, Psychophysiology.

[10]  K. Domschke,et al.  Novel developments in genetic and epigenetic mechanisms of anxiety , 2016, Current opinion in psychiatry.

[11]  D. Chambless,et al.  A systematic review of predictors and moderators of improvement in cognitive-behavioral therapy for panic disorder and agoraphobia. , 2015, Clinical psychology review.

[12]  A. Gloster,et al.  The role of safety behaviors in exposure-based treatment for panic disorder and agoraphobia: associations to symptom severity, treatment course, and outcome. , 2014, Journal of anxiety disorders.

[13]  Dan J Stein,et al.  Arousal and the attentional network in panic disorder , 2014, Human psychopharmacology.

[14]  R. Maldonado,et al.  The Hypocretin/Orexin System Mediates the Extinction of Fear Memories , 2014, Neuropsychopharmacology.

[15]  Takeshi Sakurai,et al.  The role of orexin in motivated behaviours , 2014, Nature Reviews Neuroscience.

[16]  D. Galimberti,et al.  Is HCRTR2 a Genetic Risk Factor for Alzheimer's Disease? , 2014, Dementia and Geriatric Cognitive Disorders.

[17]  T. Sakurai,et al.  OX1 and OX2 orexin/hypocretin receptor pharmacogenetics , 2014, Front. Neurosci..

[18]  R. Peeters,et al.  Brainstem response to hypercapnia: A symptom provocation study into the pathophysiology of panic disorder , 2014, Journal of psychopharmacology.

[19]  C. H. Summers,et al.  Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala , 2014, Psychoneuroendocrinology.

[20]  C. Leonard,et al.  Orexin/hypocretin receptor signalling: a functional perspective , 2014, British journal of pharmacology.

[21]  C S Leonard,et al.  Orexin/hypocretin receptor signalling cascades , 2014, British journal of pharmacology.

[22]  M. Höfler,et al.  MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy , 2014, Molecular Psychiatry.

[23]  A. Serretti,et al.  Personalized therapies in psychiatry: promises, pitfalls and perspectives , 2014, Journal of Neural Transmission.

[24]  Robert M Sears,et al.  Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus , 2013, Proceedings of the National Academy of Sciences.

[25]  T. Sakurai,et al.  Orexin Receptor-1 in the Locus Coeruleus Plays an Important Role in Cue-Dependent Fear Memory Consolidation , 2013, The Journal of Neuroscience.

[26]  C. Harmer,et al.  Changes in Automatic Threat Processing Precede and Predict Clinical Changes with Exposure-Based Cognitive-Behavior Therapy for Panic Disorder , 2013, Biological Psychiatry.

[27]  C. Lowry,et al.  Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network , 2012, Physiology & Behavior.

[28]  G. Alpers,et al.  Meta‐analysis argues for a female‐specific role of MAOA‐uVNTR in panic disorder in four European populations , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[29]  A. Gloster,et al.  Dynamics of Defensive Reactivity in Patients with Panic Disorder and Agoraphobia: Implications for the Etiology of Panic Disorder , 2012, Biological Psychiatry.

[30]  M. Posner,et al.  The attention system of the human brain: 20 years after. , 2012, Annual review of neuroscience.

[31]  S. Lightman,et al.  Activation of the Orexin 1 Receptor is a Critical Component of CO2-Mediated Anxiety and Hypertension but not Bradycardia , 2012, Neuropsychopharmacology.

[32]  A. Shekhar,et al.  Orexin, stress, and anxiety/panic states. , 2012, Progress in brain research.

[33]  M. Herrmann,et al.  Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder , 2012, Journal of Neural Transmission.

[34]  Gary King,et al.  MatchIt: Nonparametric Preprocessing for Parametric Causal Inference , 2011 .

[35]  Tilo Kircher,et al.  Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. , 2011, Journal of consulting and clinical psychology.

[36]  C. Allgulander,et al.  Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene , 2011, Psychiatric genetics.

[37]  C. Marker,et al.  Catastrophic misinterpretations as a predictor of symptom change during treatment for panic disorder. , 2010, Journal of consulting and clinical psychology.

[38]  V. Arolt,et al.  Neural correlates of trait anxiety in fear extinction , 2010, Psychological Medicine.

[39]  K. Domschke,et al.  Interoceptive sensitivity in anxiety and anxiety disorders: an overview and integration of neurobiological findings. , 2010, Clinical psychology review.

[40]  A. Shekhar,et al.  A KEY ROLE FOR OREXIN IN PANIC ANXIETY , 2009, Nature Medicine.

[41]  M. Höfler,et al.  Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[42]  M. Posner,et al.  Research on attention networks as a model for the integration of psychological science. , 2007, Annual review of psychology.

[43]  T. Shinkai,et al.  The Orexin 1 Receptor (HCRTR1) Gene as a Susceptibility Gene Contributing to Polydipsia-Hyponatremia in Schizophrenia , 2007, NeuroMolecular Medicine.

[44]  Katharina Domschke,et al.  Meta‐analysis of COMT val158met in panic disorder: Ethnic heterogeneity and gender specificity , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[45]  Gary King,et al.  Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference , 2007, Political Analysis.

[46]  Jan Friso Groote,et al.  20 Years After , 2007 .

[47]  R. Salomon,et al.  Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects , 2003, Biological Psychiatry.

[48]  O. Jöhren,et al.  Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus , 2002, Peptides.

[49]  C. Saper,et al.  Differential expression of orexin receptors 1 and 2 in the rat brain , 2001, The Journal of comparative neurology.

[50]  S. Mineka,et al.  A modern learning theory perspective on the etiology of panic disorder. , 2001, Psychological review.

[51]  M. I. Smith,et al.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[53]  S. Carr,et al.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.

[54]  W. Whitelaw,et al.  Agoraphobic avoidance and panic frequency as predictors of laboratory induced panic reactions. , 1992, Behaviour research and therapy.

[55]  G. Zgourides,et al.  Relationships between catastrophic cognitions and body sensations in anxiety disordered, mixed diagnosis, and normal subjects. , 1990, Behaviour research and therapy.